Question 1

What is adult-onset proximal spinal muscular atrophy, autosomal dominant?

Accepted Answer

Adult-onset proximal spinal muscular atrophy, autosomal dominant is a rare neuromuscular condition. It is also known by several other names such as Finkel disease, autosomal dominant late-onset spinal muscular atrophy, and Finkel type among others. Information about the overall characteristics and definition of this condition is currently limited for this condition.

Question 2

What are the symptoms of adult-onset proximal spinal muscular atrophy, autosomal dominant?

Accepted Answer

Information about symptoms is currently limited for this condition.

Question 3

What causes adult-onset proximal spinal muscular atrophy, autosomal dominant?

Accepted Answer

This condition is inherited in an autosomal dominant pattern. It has been associated with changes in the VAPB gene. Further details about the underlying causes and risk factors are currently limited for this condition. Associated genes include VAPB.

Question 4

How is adult-onset proximal spinal muscular atrophy, autosomal dominant inherited?

Accepted Answer

adult-onset proximal spinal muscular atrophy, autosomal dominant follows an autosomal dominant inheritance pattern. This means inheriting just one copy of the altered gene from either parent can cause the condition.

Question 5

How rare is adult-onset proximal spinal muscular atrophy, autosomal dominant?

Accepted Answer

adult-onset proximal spinal muscular atrophy, autosomal dominant is classified as rare. The estimated prevalence is approximately 1-9 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is adult-onset proximal spinal muscular atrophy, autosomal dominant diagnosed?

Accepted Answer

Information about diagnosis is currently limited for this condition.

Question 7

Are there treatments for adult-onset proximal spinal muscular atrophy, autosomal dominant?

Accepted Answer

Information about treatment options and management is currently limited for this condition. FDA-approved treatments include SPINRAZA, Zolgensma, EVRYSDI.

Question 8

What complications can arise from adult-onset proximal spinal muscular atrophy, autosomal dominant?

Accepted Answer

Complications from adult-onset proximal spinal muscular atrophy, autosomal dominant can include muscle weakness and difficulty with mobility. As the condition progresses, it may affect daily activities and lead to challenges in maintaining independence. However, specific complications are not well-documented due to limited information about this condition.

Question 9

How does adult-onset proximal spinal muscular atrophy, autosomal dominant affect daily life?

Accepted Answer

Living with adult-onset proximal spinal muscular atrophy, autosomal dominant may require adjustments in daily activities. Individuals might experience challenges with tasks that require strength and coordination. Support from family, friends, and healthcare providers can help improve quality of life and manage these challenges.

Question 10

What is the prognosis for someone with adult-onset proximal spinal muscular atrophy, autosomal dominant?

Accepted Answer

The prognosis for adult-onset proximal spinal muscular atrophy, autosomal dominant is not well-defined due to limited information. However, since it is a neuromuscular condition, individuals may experience a gradual progression of symptoms. It's important to work closely with healthcare providers to monitor the condition and plan for future care.

Question 11

Are there any specialist recommendations for managing adult-onset proximal spinal muscular atrophy, autosomal dominant?

Accepted Answer

While specific specialist recommendations for adult-onset proximal spinal muscular atrophy, autosomal dominant are not detailed, it is generally advisable to consult with a neurologist or a specialist in neuromuscular disorders. These professionals can provide guidance on managing symptoms and improving quality of life. Regular follow-ups are important to address any changes in health.

Organ System	Phenotype Count	Example Features
Muscles	6	Muscle spasm, Distal muscle weakness, Fasciculations
Brain and nerves	4	Hyporeflexia, EMG: neuropathic changes, Fasciculations

Brand Name	Generic Name	Mechanism	Approved	Market Status
EVRYSDI	RISDIPLAM	—	2020	Available
Zolgensma	onasemnogene abeparvovec-xioi	—	2019	Available
SPINRAZA	NUSINERSEN	—	2016	Available

Research Type	Count	% of Total
Laboratory research	27	23%
Clinical study results	26	22%
Disease patterns and progression	26	22%
Research summaries	12	10%
Patient case studies	9	8%
Testing and diagnosis research	8	7%
New treatment approaches	6	5%
Other research	2	2%

Kisho

adult-onset proximal spinal muscular atrophy, autosomal dominant

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Treatment

Approved Therapies

Clinical Trials

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

adult-onset proximal spinal muscular atrophy, autosomal dominant

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Treatment

Approved Therapies

Clinical Trials

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is adult-onset proximal spinal muscular atrophy, autosomal dominant?

What are the symptoms of adult-onset proximal spinal muscular atrophy, autosomal dominant?

What causes adult-onset proximal spinal muscular atrophy, autosomal dominant?

How is adult-onset proximal spinal muscular atrophy, autosomal dominant inherited?

How rare is adult-onset proximal spinal muscular atrophy, autosomal dominant?

How is adult-onset proximal spinal muscular atrophy, autosomal dominant diagnosed?

Are there treatments for adult-onset proximal spinal muscular atrophy, autosomal dominant?

What complications can arise from adult-onset proximal spinal muscular atrophy, autosomal dominant?

How does adult-onset proximal spinal muscular atrophy, autosomal dominant affect daily life?

What is the prognosis for someone with adult-onset proximal spinal muscular atrophy, autosomal dominant?

Are there any specialist recommendations for managing adult-onset proximal spinal muscular atrophy, autosomal dominant?